{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:55:06Z","timestamp":1790553306586,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Muscle"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Presently, there is no effective treatment for the lethal muscle wasting disease Duchenne muscular dystrophy (DMD). Here we show that increased sphingosine-1-phoshate (S1P) through direct injection or via the administration of the small molecule 2-acetyl-4(5)-tetrahydroxybutyl imidazole (THI), an S1P lyase inhibitor, has beneficial effects in acutely injured dystrophic muscles of <jats:italic>mdx<\/jats:italic> mice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We treated <jats:italic>mdx<\/jats:italic> mice with and without acute injury and characterized the histopathological and functional effects of increasing S1P levels. We also tested exogenous and direct administration of S1P on <jats:italic>mdx<\/jats:italic> muscles to examine the molecular pathways under which S1P promotes regeneration in dystrophic muscles.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Short-term treatment with THI significantly increased muscle fiber size and extensor digitorum longus (EDL) muscle specific force in acutely injured <jats:italic>mdx<\/jats:italic> limb muscles. In addition, the accumulation of fibrosis and fat deposition, hallmarks of DMD pathology and impaired muscle regeneration, were lower in the injured muscles of THI-treated <jats:italic>mdx<\/jats:italic> mice. Furthermore, increased muscle force was observed in uninjured EDL muscles with a longer-term treatment of THI. Such regenerative effects were linked to the response of myogenic cells, since intramuscular injection of S1P increased the number of <jats:italic>Myf5<\/jats:italic>\n              <jats:sup>\n                <jats:italic>nlacz\/+<\/jats:italic>\n              <\/jats:sup> positive myogenic cells and newly regenerated myofibers in injured <jats:italic>mdx<\/jats:italic> muscles. Intramuscular injection of biotinylated-S1P localized to muscle fibers, including newly regenerated fibers, which also stained positive for S1P receptor 1 (S1PR1). Importantly, plasma membrane and perinuclear localization of phosphorylated S1PR1 was observed in regenerating muscle fibers of <jats:italic>mdx<\/jats:italic> muscles. Intramuscular increases of S1P levels, S1PR1 and phosphorylated ribosomal protein S6 (P-rpS6), and elevated EDL muscle specific force, suggest S1P promoted the upregulation of anabolic pathways that mediate skeletal muscle mass and function.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These data show that S1P is beneficial for muscle regeneration and functional gain in dystrophic mice, and that THI, or other pharmacological agents that raise S1P levels systemically, may be developed into an effective treatment for improving muscle function and reducing the pathology of DMD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/2044-5040-3-20","type":"journal-article","created":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T08:14:55Z","timestamp":1375344895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Increased sphingosine-1-phosphate improves muscle regeneration in acutely injured mdx mice"],"prefix":"10.1186","volume":"3","author":[{"given":"Nicholas","family":"Ieronimakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Pantoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aislinn L","family":"Hays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy L","family":"Dosey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin A","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N","family":"Hoofnagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sadilek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannele","family":"Ruohola-Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morayma","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,1]]},"reference":[{"key":"82_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2006.09.016","volume":"36","author":"N Deconinck","year":"2007","unstructured":"Deconinck N, Dan B: Pathophysiology of duchenne muscular dystrophy: current hypotheses. Pediatr Neurol. 2007, 36: 1-7. 10.1016\/j.pediatrneurol.2006.09.016.","journal-title":"Pediatr Neurol"},{"key":"82_CR2","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1177\/0883073810371005","volume":"25","author":"JR Mendell","year":"2010","unstructured":"Mendell JR, Rodino-Klapac LR, Malik V: Molecular therapeutic strategies targeting Duchenne muscular dystrophy. J Child Neurol. 2010, 25: 1145-1148. 10.1177\/0883073810371005.","journal-title":"J Child Neurol"},{"key":"82_CR3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/j.1399-3046.2010.01377.x","volume":"14","author":"B Palmieri","year":"2010","unstructured":"Palmieri B, Tremblay JP, Daniele L: Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy. Pediatr Transplant. 2010, 14: 813-819. 10.1111\/j.1399-3046.2010.01377.x.","journal-title":"Pediatr Transplant"},{"key":"82_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11010-008-9780-y","volume":"314","author":"E Rapizzi","year":"2008","unstructured":"Rapizzi E, Donati C, Cencetti F, Nincheri P, Bruni P: Sphingosine 1-phosphate differentially regulates proliferation of C2C12 reserve cells and myoblasts. Mol Cell Biochem. 2008, 314: 193-199. 10.1007\/s11010-008-9780-y.","journal-title":"Mol Cell Biochem"},{"key":"82_CR5","doi-asserted-by":"publisher","first-page":"C550","DOI":"10.1152\/ajpcell.00072.2009","volume":"298","author":"D Danieli-Betto","year":"2010","unstructured":"Danieli-Betto D, Peron S, Germinario E, Zanin M, Sorci G, Franzoso S, Sandona D, Betto R: Sphingosine 1-phosphate signaling is involved in skeletal muscle regeneration. Am J Physiol. 2010, 298: C550-C558. 10.1152\/ajpcell.00072.2009.","journal-title":"Am J Physiol"},{"key":"82_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2044-5040-2-15","volume":"2","author":"C Bernacchioni","year":"2012","unstructured":"Bernacchioni C, Cencetti F, Blescia S, Donati C, Bruni P: Sphingosine kinase\/sphingosine 1-phosphate axis: a new player for insulin-like growth factor-1-induced myoblast differentiation. Skelet Muscle. 2012, 2: 15-10.1186\/2044-5040-2-15.","journal-title":"Skelet Muscle"},{"key":"82_CR7","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1007\/s00018-008-8236-6","volume":"65","author":"P Bruni","year":"2008","unstructured":"Bruni P, Donati C: Pleiotropic effects of sphingolipids in skeletal muscle. Cell Mol Life Sci. 2008, 65: 3725-3736. 10.1007\/s00018-008-8236-6.","journal-title":"Cell Mol Life Sci"},{"key":"82_CR8","doi-asserted-by":"publisher","first-page":"e37218","DOI":"10.1371\/journal.pone.0037218","volume":"7","author":"KC Loh","year":"2012","unstructured":"Loh KC, Leong WI, Carlson ME, Oskouian B, Kumar A, Fyrst H, Zhang M, Proia RL, Hoffman EP, Saba JD: Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2\/STAT3 signaling pathway. PLoS One. 2012, 7: e37218-10.1371\/journal.pone.0037218.","journal-title":"PLoS One"},{"key":"82_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1242\/dev.087791","volume":"140","author":"M Pantoja","year":"2013","unstructured":"Pantoja M, Fischer KA, Ieronimakis N, Reyes M, Ruohola-Baker H: Genetic elevation of Sphingosine 1-phosphate suppresses dystrophic muscle phenotypes in Drosophila. Development. 2013, 140: 136-146. 10.1242\/dev.087791.","journal-title":"Development"},{"key":"82_CR10","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1021\/jm900278w","volume":"52","author":"JT Bagdanoff","year":"2009","unstructured":"Bagdanoff JT, Donoviel MS, Nouraldeen A, Tarver J, Fu Q, Carlsen M, Jessop TC, Zhang H, Hazelwood J, Nguyen H, Baugh SD, Gardyan M, Terranova KM, Barbosa J, Yan J, Bednarz M, Layek S, Courtney LF, Taylor J, Digeorge-Foushee AM, Gopinathan S, Bruce D, Smith T, Moran L, O'Neill E, Kramer J, Lai Z, Kimball SD, Liu Q, Sun W, et al: Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders. J Med Chem. 2009, 52: 3941-3953. 10.1021\/jm900278w.","journal-title":"J Med Chem"},{"key":"82_CR11","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1126\/science.1113640","volume":"309","author":"SR Schwab","year":"2005","unstructured":"Schwab SR, Pereira JP, Matloubian M, Xu Y, Huang Y, Cyster JG: Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science (New York, NY. 2005, 309: 1735-1739. 10.1126\/science.1113640.","journal-title":"Science (New York, NY"},{"key":"82_CR12","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/jb\/118.5.959","volume":"118","author":"R Matsuda","year":"1995","unstructured":"Matsuda R, Nishikawa A, Tanaka H: Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J Biochem. 1995, 118: 959-964. 10.1093\/jb\/118.5.959.","journal-title":"J Biochem"},{"key":"82_CR13","doi-asserted-by":"publisher","first-page":"e10920","DOI":"10.1371\/journal.pone.0010920","volume":"5","author":"N Ieronimakis","year":"2008","unstructured":"Ieronimakis N, Balasundaram G, Rainey S, Srirangam K, Yablonka-Reuveni Z, Reyes M: Absence of CD34 on murine skeletal muscle satellite cells marks a reversible state of activation during acute injury. PLoS One. 2008, 5: e10920-","journal-title":"PLoS One"},{"key":"82_CR14","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1161\/ATVBAHA.109.191965","volume":"29","author":"AD Grabski","year":"2009","unstructured":"Grabski AD, Shimizu T, Deou J, Mahoney WM, Reidy MA, Daum G: Sphingosine-1-phosphate receptor-2 regulates expression of smooth muscle alpha-actin after arterial injury. Arterioscler Thromb Vasc Biol. 2009, 29: 1644-1650. 10.1161\/ATVBAHA.109.191965.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"82_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1365-2613.2010.00750.x","volume":"92","author":"CG Au","year":"2011","unstructured":"Au CG, Butler TL, Sherwood MC, Egan JR, North KN, Winlaw DS: Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy. Int J Exp Pathol. 2011, 92: 57-65. 10.1111\/j.1365-2613.2010.00750.x.","journal-title":"Int J Exp Pathol"},{"key":"82_CR16","doi-asserted-by":"publisher","first-page":"C1367","DOI":"10.1152\/ajpcell.00246.2004","volume":"288","author":"D Danieli-Betto","year":"2005","unstructured":"Danieli-Betto D, Germinario E, Esposito A, Megighian A, Midrio M, Ravara B, Damiani E, Libera LD, Sabbadini RA, Betto R: Sphingosine 1-phosphate protects mouse extensor digitorum longus skeletal muscle during fatigue. Am J Physiol. 2005, 288: C1367-C1373. 10.1152\/ajpcell.00246.2004.","journal-title":"Am J Physiol"},{"key":"82_CR17","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/S0002-9440(10)64502-6","volume":"161","author":"P Gregorevic","year":"2002","unstructured":"Gregorevic P, Plant DR, Leeding KS, Bach LA, Lynch GS: Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration. Am J Pathol. 2002, 161: 2263-2272. 10.1016\/S0002-9440(10)64502-6.","journal-title":"Am J Pathol"},{"key":"82_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/mus.20082","volume":"30","author":"P Gregorevic","year":"2004","unstructured":"Gregorevic P, Plant DR, Lynch GS: Administration of insulin-like growth factor-I improves fatigue resistance of skeletal muscles from dystrophic mdx mice. Muscle Nerve. 2004, 30: 295-304. 10.1002\/mus.20082.","journal-title":"Muscle Nerve"},{"key":"82_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1006\/abio.2001.5063","volume":"292","author":"DL Baker","year":"2001","unstructured":"Baker DL, Desiderio DM, Miller DD, Tolley B, Tigyi GJ: Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry. Anal Biochem. 2001, 292: 287-295. 10.1006\/abio.2001.5063.","journal-title":"Anal Biochem"},{"key":"82_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1042\/bj0610116","volume":"61","author":"IT Oliver","year":"1955","unstructured":"Oliver IT: A spectrophotometric method for the determination of creatine phosphokinase and myokinase. Biochem J. 1955, 61: 116-122.","journal-title":"Biochem J"},{"key":"82_CR21","volume-title":"Histological and Histochemical Methods: Theory and Practice","author":"J Kiernan","year":"2008","unstructured":"Kiernan J: Histological and Histochemical Methods: Theory and Practice. 2008, New York: Cold Spring Harbor Laboratory Press, 4","edition":"4"},{"key":"82_CR22","doi-asserted-by":"publisher","first-page":"C1087","DOI":"10.1152\/ajpcell.00388.2009","volume":"298","author":"JL Clever","year":"2010","unstructured":"Clever JL, Sakai Y, Wang RA, Schneider DB: Inefficient skeletal muscle repair in inhibitor of differentiation knockout mice suggests a crucial role for BMP signaling during adult muscle regeneration. Am J Physiol. 2010, 298: C1087-C1099. 10.1152\/ajpcell.00388.2009.","journal-title":"Am J Physiol"},{"key":"82_CR23","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1073\/pnas.86.4.1292","volume":"86","author":"VM Chapman","year":"1989","unstructured":"Chapman VM, Miller DR, Armstrong D, Caskey CT: Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc Natl Acad Sci USA. 1989, 86: 1292-1296. 10.1073\/pnas.86.4.1292.","journal-title":"Proc Natl Acad Sci USA"},{"key":"82_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0022-510X(94)00276-T","volume":"129","author":"C Pastoret","year":"1995","unstructured":"Pastoret C, Sebille A: mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci. 1995, 129: 97-105. 10.1016\/0022-510X(94)00276-T.","journal-title":"J Neurol Sci"},{"key":"82_CR25","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1006\/bbrc.1997.7993","volume":"242","author":"J Zhou","year":"1998","unstructured":"Zhou J, Saba JD: Identification of the first mammalian sphingosine phosphate lyase gene and its functional expression in yeast. Biochem Biophys Res Commun. 1998, 242: 502-507. 10.1006\/bbrc.1997.7993.","journal-title":"Biochem Biophys Res Commun"},{"key":"82_CR26","doi-asserted-by":"publisher","first-page":"22341","DOI":"10.1074\/jbc.M302857200","volume":"278","author":"J Mendel","year":"2003","unstructured":"Mendel J, Heinecke K, Fyrst H, Saba JD: Sphingosine phosphate lyase expression is essential for normal development in Caenorhabditis elegans. J Biol Chem. 2003, 278: 22341-22349. 10.1074\/jbc.M302857200.","journal-title":"J Biol Chem"},{"key":"82_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1432-1033.1988.tb14068.x","volume":"174","author":"A d\u2019Albis","year":"1988","unstructured":"d\u2019Albis A, Couteaux R, Janmot C, Roulet A, Mira JC: Regeneration after cardiotoxin injury of innervated and denervated slow and fast muscles of mammals. Myosin isoform analysis. E J Biochem. 1988, 174: 103-110. 10.1111\/j.1432-1033.1988.tb14068.x.","journal-title":"E J Biochem"},{"key":"82_CR28","doi-asserted-by":"publisher","first-page":"8826","DOI":"10.1074\/jbc.M209879200","volume":"278","author":"Z Yan","year":"2003","unstructured":"Yan Z, Choi S, Liu X, Zhang M, Schageman JJ, Lee SY, Hart R, Lin L, Thurmond FA, Williams RS: Highly coordinated gene regulation in mouse skeletal muscle regeneration. J Biol Chem. 2003, 278: 8826-8836. 10.1074\/jbc.M209879200.","journal-title":"J Biol Chem"},{"key":"82_CR29","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/mus.21624","volume":"41","author":"E Mouisel","year":"2010","unstructured":"Mouisel E, Vignaud A, Hourde C, Butler-Browne G, Ferry A: Muscle weakness and atrophy are associated with decreased regenerative capacity and changes in mTOR signaling in skeletal muscles of venerable (18-24-month-old) dystrophic mdx mice. Muscle Nerve. 2010, 41: 809-818. 10.1002\/mus.21624.","journal-title":"Muscle Nerve"},{"key":"82_CR30","doi-asserted-by":"publisher","first-page":"e10920","DOI":"10.1371\/journal.pone.0010920","volume":"5","author":"N Ieronimakis","year":"2010","unstructured":"Ieronimakis N, Balasundaram G, Rainey S, Srirangam K, Yablonka-Reuveni Z, Reyes M: Absence of CD34 on murine skeletal muscle satellite cells marks a reversible state of activation during acute injury. PLoS One. 2010, 5: e10920-10.1371\/journal.pone.0010920.","journal-title":"PLoS One"},{"key":"82_CR31","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/mus.880110809","volume":"11","author":"MJ Glesby","year":"1988","unstructured":"Glesby MJ, Rosenmann E, Nylen EG, Wrogemann K: Serum CK, calcium, magnesium, and oxidative phosphorylation in mdx mouse muscular dystrophy. Muscle Nerve. 1988, 11: 852-856. 10.1002\/mus.880110809.","journal-title":"Muscle Nerve"},{"key":"82_CR32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00418-004-0707-8","volume":"122","author":"MC Salimena","year":"2004","unstructured":"Salimena MC, Lagrota-Candido J, Quirico-Santos T: Gender dimorphism influences extracellular matrix expression and regeneration of muscular tissue in mdx dystrophic mice. Histochem Cell Biol. 2004, 122: 435-444.","journal-title":"Histochem Cell Biol"},{"key":"82_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00314217","volume":"236","author":"D Cros","year":"1989","unstructured":"Cros D, Harnden P, Pellissier JF, Serratrice G: Muscle hypertrophy in Duchenne muscular dystrophy. A pathological and morphometric study. J Neurol. 1989, 236: 43-47. 10.1007\/BF00314217.","journal-title":"J Neurol"},{"key":"82_CR34","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1242\/dev.064162","volume":"138","author":"MM Murphy","year":"2011","unstructured":"Murphy MM, Lawson JA, Mathew SJ, Hutcheson DA, Kardon G: Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. Development. 2011, 138: 3625-3637. 10.1242\/dev.064162.","journal-title":"Development"},{"key":"82_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2044-5040-1-21","volume":"1","author":"CJ Mann","year":"2011","unstructured":"Mann CJ, Perdiguero E, Kharraz Y, Aguilar S, Pessina P, Serrano AL, Munoz-Canoves P: Aberrant repair and fibrosis development in skeletal muscle. Skelet Muscle. 2011, 1: 21-10.1186\/2044-5040-1-21.","journal-title":"Skelet Muscle"},{"key":"82_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1046\/j.0021-8782.2001.00008.x","volume":"200","author":"PW Hamer","year":"2002","unstructured":"Hamer PW, McGeachie JM, Davies MJ, Grounds MD: Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability. J Anat. 2002, 200: 69-79. 10.1046\/j.0021-8782.2001.00008.x.","journal-title":"J Anat"},{"key":"82_CR37","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1016\/j.yexcr.2006.04.024","volume":"312","author":"AK Peter","year":"2006","unstructured":"Peter AK, Crosbie RH: Hypertrophic response of Duchenne and limb-girdle muscular dystrophies is associated with activation of Akt pathway. Exp Cell Res. 2006, 312: 2580-2591. 10.1016\/j.yexcr.2006.04.024.","journal-title":"Exp Cell Res"},{"key":"82_CR38","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/dvdy.20151","volume":"231","author":"O Halevy","year":"2004","unstructured":"Halevy O, Piestun Y, Allouh MZ, Rosser BW, Rinkevich Y, Reshef R, Rozenboim I, Wleklinski-Lee M, Yablonka-Reuveni Z: Pattern of Pax7 expression during myogenesis in the posthatch chicken establishes a model for satellite cell differentiation and renewal. Dev Dyn. 2004, 231: 489-502. 10.1002\/dvdy.20151.","journal-title":"Dev Dyn"},{"key":"82_CR39","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0960-8966(99)00118-2","volume":"10","author":"J Reimann","year":"2000","unstructured":"Reimann J, Irintchev A, Wernig A: Regenerative capacity and the number of satellite cells in soleus muscles of normal and mdx mice. Neuromuscul Disord. 2000, 10: 276-282. 10.1016\/S0960-8966(99)00118-2.","journal-title":"Neuromuscul Disord"},{"key":"82_CR40","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0092-8674(00)00066-0","volume":"102","author":"P Seale","year":"2000","unstructured":"Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA: Pax7 is required for the specification of myogenic satellite cells. Cell. 2000, 102: 777-786. 10.1016\/S0092-8674(00)00066-0.","journal-title":"Cell"},{"key":"82_CR41","doi-asserted-by":"publisher","first-page":"685","DOI":"10.5483\/BMBRep.2009.42.10.685","volume":"42","author":"K Heo","year":"2009","unstructured":"Heo K, Park KA, Kim YH, Kim SH, Oh YS, Kim IH, Ryu SH, Suh PG: Sphingosine 1-phosphate induces vascular endothelial growth factor expression in endothelial cells. BMB Rep. 2009, 42: 685-690. 10.5483\/BMBRep.2009.42.10.685.","journal-title":"BMB Rep"},{"issue":"Pt 1","key":"82_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1042\/bj3480071","volume":"348","author":"T Kimura","year":"2000","unstructured":"Kimura T, Watanabe T, Sato K, Kon J, Tomura H, Tamama K, Kuwabara A, Kanda T, Kobayashi I, Ohta H, Ui M, Okajima F: Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. Biochem J. 2000, 348 (Pt 1): 71-76.","journal-title":"Biochem J"},{"key":"82_CR43","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1161\/hq0102.101843","volume":"22","author":"Y Rikitake","year":"2002","unstructured":"Rikitake Y, Hirata K, Kawashima S, Ozaki M, Takahashi T, Ogawa W, Inoue N, Yokoyama M: Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis. Arterioscler Thromb Vasc Biol. 2002, 22: 108-114. 10.1161\/hq0102.101843.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"82_CR44","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1177\/002215549704500406","volume":"45","author":"HI Yeh","year":"1997","unstructured":"Yeh HI, Dupont E, Coppen S, Rothery S, Severs NJ: Gap junction localization and connexin expression in cytochemically identified endothelial cells of arterial tissue. J Histochem Cytochem. 1997, 45: 539-550. 10.1177\/002215549704500406.","journal-title":"J Histochem Cytochem"},{"key":"82_CR45","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ejpn.2005.06.004","volume":"9","author":"EA Beenakker","year":"2005","unstructured":"Beenakker EA, Maurits NM, Fock JM, Brouwer OF, van der Hoeven JH: Functional ability and muscle force in healthy children and ambulant Duchenne muscular dystrophy patients. Eur J Paediatr Neurol. 2005, 9: 387-393. 10.1016\/j.ejpn.2005.06.004.","journal-title":"Eur J Paediatr Neurol"},{"key":"82_CR46","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1469-7793.2001.00591.x","volume":"535","author":"GS Lynch","year":"2001","unstructured":"Lynch GS, Hinkle RT, Chamberlain JS, Brooks SV, Faulkner JA: Force and power output of fast and slow skeletal muscles from mdx mice 6\u201328 months old. J Physiol. 2001, 535: 591-600. 10.1111\/j.1469-7793.2001.00591.x.","journal-title":"J Physiol"},{"key":"82_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1083\/jcb.200605028","volume":"174","author":"Y Nagata","year":"2006","unstructured":"Nagata Y, Partridge TA, Matsuda R, Zammit PS: Entry of muscle satellite cells into the cell cycle requires sphingolipid signaling. J Cell Biol. 2006, 174: 245-253. 10.1083\/jcb.200605028.","journal-title":"J Cell Biol"},{"key":"82_CR48","first-page":"299","volume":"3","author":"SJ Frank","year":"1991","unstructured":"Frank SJ, Engel I, Rutledge TM, Letourneur F: Structure\/function analysis of the invariant subunits of the T cell antigen receptor. Semin Immunol. 1991, 3: 299-311.","journal-title":"Semin Immunol"},{"key":"82_CR49","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D","volume":"206","author":"S Tajbakhsh","year":"1996","unstructured":"Tajbakhsh S, Bober E, Babinet C, Pournin S, Arnold H, Buckingham M: Gene targeting the myf-5 locus with nlacZ reveals expression of this myogenic factor in mature skeletal muscle fibres as well as early embryonic muscle. Dev Dyn. 1996, 206: 291-300. 10.1002\/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D.","journal-title":"Dev Dyn"},{"key":"82_CR50","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1083\/jcb.151.6.1221","volume":"151","author":"JR Beauchamp","year":"2000","unstructured":"Beauchamp JR, Heslop L, Yu DS, Tajbakhsh S, Kelly RG, Wernig A, Buckingham ME, Partridge TA, Zammit PS: Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol. 2000, 151: 1221-1234. 10.1083\/jcb.151.6.1221.","journal-title":"J Cell Biol"},{"key":"82_CR51","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ydbio.2006.12.026","volume":"304","author":"K Day","year":"2007","unstructured":"Day K, Shefer G, Richardson JB, Enikolopov G, Yablonka-Reuveni Z: Nestin-GFP reporter expression defines the quiescent state of skeletal muscle satellite cells. Dev Biol. 2007, 304: 246-259. 10.1016\/j.ydbio.2006.12.026.","journal-title":"Dev Biol"},{"key":"82_CR52","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1146\/annurev.biochem.78.072407.103733","volume":"78","author":"H Rosen","year":"2009","unstructured":"Rosen H, Gonzalez-Cabrera PJ, Sanna MG, Brown S: Sphingosine 1-phosphate receptor signaling. Annu Rev Biochem. 2009, 78: 743-768. 10.1146\/annurev.biochem.78.072407.103733.","journal-title":"Annu Rev Biochem"},{"key":"82_CR53","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1091\/mbc.10.4.1179","volume":"10","author":"CH Liu","year":"1999","unstructured":"Liu CH, Thangada S, Lee MJ, Van Brocklyn JR, Spiegel S, Hla T: Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1. Mol Biol Cell. 1999, 10: 1179-1190. 10.1091\/mbc.10.4.1179.","journal-title":"Mol Biol Cell"},{"key":"82_CR54","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1172\/JCI45403","volume":"121","author":"ML Oo","year":"2011","unstructured":"Oo ML, Chang SH, Thangada S, Wu MT, Rezaul K, Blaho V, Hwang SI, Han DK, Hla T: Engagement of S1P(1)-degradative mechanisms leads to vascular leak in mice. J Clin Invest. 2011, 121: 2290-2300. 10.1172\/JCI45403.","journal-title":"J Clin Invest"},{"key":"82_CR55","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00418-008-0521-9","volume":"131","author":"R Estrada","year":"2009","unstructured":"Estrada R, Wang L, Jala VR, Lee JF, Lin CY, Gray RD, Haribabu B, Lee MJ: Ligand-induced nuclear translocation of S1P(1) receptors mediates Cyr61 and CTGF transcription in endothelial cells. Histochem Cell Biol. 2009, 131: 239-249. 10.1007\/s00418-008-0521-9.","journal-title":"Histochem Cell Biol"},{"key":"82_CR56","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1161\/hh1801.096338","volume":"89","author":"MJ Kluk","year":"2001","unstructured":"Kluk MJ, Hla T: Role of the sphingosine 1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration. Circ Res. 2001, 89: 496-502. 10.1161\/hh1801.096338.","journal-title":"Circ Res"},{"key":"82_CR57","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1006\/jmcc.2001.1433","volume":"33","author":"P Robert","year":"2001","unstructured":"Robert P, Tsui P, Laville MP, Livi GP, Sarau HM, Bril A, Berrebi-Bertrand I: EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes. J Mol Cell Cardiol. 2001, 33: 1589-1606. 10.1006\/jmcc.2001.1433.","journal-title":"J Mol Cell Cardiol"},{"key":"82_CR58","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ncb1101-1014","volume":"3","author":"SC Bodine","year":"2001","unstructured":"Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD: Akt\/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol. 2001, 3: 1014-1019. 10.1038\/ncb1101-1014.","journal-title":"Nat Cell Biol"},{"key":"82_CR59","doi-asserted-by":"publisher","first-page":"9295","DOI":"10.1128\/MCB.24.21.9295-9304.2004","volume":"24","author":"KM Lai","year":"2004","unstructured":"Lai KM, Gonzalez M, Poueymirou WT, Kline WO, Na E, Zlotchenko E, Stitt TN, Economides AN, Yancopoulos GD, Glass DJ: Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol. 2004, 24: 9295-9304. 10.1128\/MCB.24.21.9295-9304.2004.","journal-title":"Mol Cell Biol"},{"key":"82_CR60","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4067\/S0716-97602002000200022","volume":"35","author":"G Thomas","year":"2002","unstructured":"Thomas G: The S6 kinase signaling pathway in the control of development and growth. Biol Res. 2002, 35: 305-313.","journal-title":"Biol Res"},{"key":"82_CR61","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/hmg\/8.5.855","volume":"8","author":"LV Anderson","year":"1999","unstructured":"Anderson LV, Davison K, Moss JA, Young C, Cullen MJ, Walsh J, Johnson MA, Bashir R, Britton S, Keers S, Argov Z, Mahjneh I, Fougerousse F, Beckmann JS, Bushby KM: Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet. 1999, 8: 855-861. 10.1093\/hmg\/8.5.855.","journal-title":"Hum Mol Genet"},{"key":"82_CR62","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1093\/hmg\/ddh212","volume":"13","author":"M Ho","year":"2004","unstructured":"Ho M, Post CM, Donahue LR, Lidov HG, Bronson RT, Goolsby H, Watkins SC, Cox GA, Brown RH: Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. Hum Mol Genet. 2004, 13: 1999-2010. 10.1093\/hmg\/ddh212.","journal-title":"Hum Mol Genet"},{"key":"82_CR63","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2353\/ajpath.2009.090107","volume":"175","author":"DP Millay","year":"2009","unstructured":"Millay DP, Maillet M, Roche JA, Sargent MA, McNally EM, Bloch RJ, Molkentin JD: Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy. Am J Pathol. 2009, 175: 1817-1823. 10.2353\/ajpath.2009.090107.","journal-title":"Am J Pathol"},{"key":"82_CR64","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/2044-5040-1-35","volume":"1","author":"R Han","year":"2011","unstructured":"Han R, Rader EP, Levy JR, Bansal D, Campbell KP: Dystrophin deficiency exacerbates skeletal muscle pathology in dysferlin-null mice. Skelet Muscle. 2011, 1: 35-10.1186\/2044-5040-1-35.","journal-title":"Skelet Muscle"},{"key":"82_CR65","first-page":"938","volume":"45","author":"M Aoki","year":"2005","unstructured":"Aoki M, Takahashi T: [Mutational and clinical features of Japanese patients with dysferlinopathy (Miyoshi myopathy and limb girdle muscular dystrophy type 2B)]. Rinsho shinkeigaku. 2005, 45: 938-942. Article in Japanese","journal-title":"Rinsho shinkeigaku"},{"key":"82_CR66","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1046\/j.1365-2990.2002.00417.x","volume":"28","author":"M Fanin","year":"2002","unstructured":"Fanin M, Angelini C: Muscle pathology in dysferlin deficiency. Neuropathol Appl Neurobiol. 2002, 28: 461-470. 10.1046\/j.1365-2990.2002.00417.x.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"82_CR67","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.yexcr.2012.03.010","volume":"318","author":"A Farini","year":"2012","unstructured":"Farini A, Sitzia C, Navarro C, D\u2019Antona G, Belicchi M, Parolini D, Del Fraro G, Razini P, Bottinelli R, Meregalli M, Torrente Y: Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model. Exp Cell Res. 2012, 318: 1160-1174. 10.1016\/j.yexcr.2012.03.010.","journal-title":"Exp Cell Res"},{"key":"82_CR68","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1152\/jappl.1999.86.3.924","volume":"86","author":"A Mokhtarian","year":"1999","unstructured":"Mokhtarian A, Lefaucheur JP, Even PC, Sebille A: Hindlimb immobilization applied to 21-day-old mdx mice prevents the occurrence of muscle degeneration. J Appl Physiol. 1999, 86: 924-931.","journal-title":"J Appl Physiol"},{"issue":"Pt 2","key":"82_CR69","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/brain\/110.2.269","volume":"110","author":"LF Torres","year":"1987","unstructured":"Torres LF, Duchen LW: The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates. Brain. 1987, 110 (Pt 2): 269-299.","journal-title":"Brain"},{"key":"82_CR70","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/0012-1606(91)90340-9","volume":"148","author":"JX DiMario","year":"1991","unstructured":"DiMario JX, Uzman A, Strohman RC: Fiber regeneration is not persistent in dystrophic (MDX) mouse skeletal muscle. Dev Biol. 1991, 148: 314-321. 10.1016\/0012-1606(91)90340-9.","journal-title":"Dev Biol"},{"key":"82_CR71","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.bbrc.2004.10.036","volume":"325","author":"M Ikeda","year":"2004","unstructured":"Ikeda M, Kihara A, Igarashi Y: Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5\u2032-phosphate binding domain exposed to the cytosol. Biochem Biophys Res Commun. 2004, 325: 338-343. 10.1016\/j.bbrc.2004.10.036.","journal-title":"Biochem Biophys Res Commun"},{"key":"82_CR72","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.1176709","volume":"325","author":"NC Hait","year":"2009","unstructured":"Hait NC, Allegood J, Maceyka M, Strub GM, Harikumar KB, Singh SK, Luo C, Marmorstein R, Kordula T, Milstien S, Spiegel S: Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science. 2009, 325: 1254-1257. 10.1126\/science.1176709.","journal-title":"Science"},{"key":"82_CR73","doi-asserted-by":"publisher","first-page":"19183","DOI":"10.1073\/pnas.0805514105","volume":"105","author":"C Colussi","year":"2008","unstructured":"Colussi C, Mozzetta C, Gurtner A, Illi B, Rosati J, Straino S, Ragone G, Pescatori M, Zaccagnini G, Antonini A, Minetti G, Martelli F, Piaggio G, Gallinari P, Steinkuhler C, Clementi E, Dell'Aversana C, Altucci L, Mai A, Capogrossi MC, Puri PL, Gaetano C: HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci USA. 2008, 105: 19183-19187. 10.1073\/pnas.0805514105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"82_CR74","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1534-5807(04)00107-8","volume":"6","author":"S Iezzi","year":"2004","unstructured":"Iezzi S, Di Padova M, Serra C, Caretti G, Simone C, Maklan E, Minetti G, Zhao P, Hoffman EP, Puri PL, Sartorelli V: Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. Dev Cell. 2004, 6: 673-684. 10.1016\/S1534-5807(04)00107-8.","journal-title":"Dev Cell"},{"key":"82_CR75","doi-asserted-by":"publisher","first-page":"C1124","DOI":"10.1152\/ajpcell.00043.2009","volume":"297","author":"MR Morissette","year":"2009","unstructured":"Morissette MR, Cook SA, Buranasombati C, Rosenberg MA, Rosenzweig A: Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt. Am J Physiol. 2009, 297: C1124-C1132. 10.1152\/ajpcell.00043.2009.","journal-title":"Am J Physiol"},{"key":"82_CR76","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/nm1202-1355","volume":"8","author":"PS Zammit","year":"2002","unstructured":"Zammit PS, Partridge TA: Sizing up muscular dystrophy. Nat Med. 2002, 8: 1355-1356. 10.1038\/nm1202-1355.","journal-title":"Nat Med"},{"key":"82_CR77","doi-asserted-by":"publisher","first-page":"43214","DOI":"10.1074\/jbc.M306709200","volume":"278","author":"SS Smyth","year":"2003","unstructured":"Smyth SS, Sciorra VA, Sigal YJ, Pamuklar Z, Wang Z, Xu Y, Prestwich GD, Morris AJ: Lipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets: studies using chemical inhibitors of lipid phosphate phosphatase activity. J Biol Chem. 2003, 278: 43214-43223. 10.1074\/jbc.M306709200.","journal-title":"J Biol Chem"},{"key":"82_CR78","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nrd3248","volume":"9","author":"V Brinkmann","year":"2010","unstructured":"Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, Francis G, Aradhye S, Burtin P: Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov. 2010, 9: 883-897. 10.1038\/nrd3248.","journal-title":"Nat Rev Drug Discov"},{"key":"82_CR79","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1124\/jpet.111.181552","volume":"338","author":"PC Kennedy","year":"2011","unstructured":"Kennedy PC, Zhu R, Huang T, Tomsig JL, Mathews TP, David M, Peyruchaud O, Macdonald TL, Lynch KR: Characterization of a sphingosine 1-phosphate receptor antagonist prodrug. J Pharmacol Exp Ther. 2011, 338: 879-889. 10.1124\/jpet.111.181552.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Skeletal Muscle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2044-5040-3-20.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:55:56Z","timestamp":1630544156000},"score":1,"resource":{"primary":{"URL":"https:\/\/skeletalmusclejournal.biomedcentral.com\/articles\/10.1186\/2044-5040-3-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["82"],"URL":"https:\/\/doi.org\/10.1186\/2044-5040-3-20","relation":{},"ISSN":["2044-5040"],"issn-type":[{"value":"2044-5040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,1]]},"assertion":[{"value":"27 November 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"20"}}